DNTH

Dianthus Therapeutics Inc. (DNTH)

US
$ 29.06-2.81%

Price Chart

Key Statistics

Market Cap
$ 619.72M
P/E Ratio
0.00
Revenue (TTM)
$ 6.52M
Volume
168.3K
52W High
$ 32.27
52W Low
$ 13.37
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
19.7212
200-Day MA
23.9509
52 Week High
32.27
52 Week Low
13.365

About DNTH

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

Employees
78
Headquarters
New York, NY
CEO
Mr. Marino Garcia M.B.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
EDBL
Edible Garden AG In...
$ 5.11
41.94
QBTS
D-Wave Quantum Inc....
$ 18.55
11.75
AAPG
Ascentage Pharma Gr...
$ 24.80
7.83
TPET
Trio Petroleum Corp...
$ 1.24
5.98
XPEV
XPeng Inc. American...
$ 20.81
5.63

Top Losers

Symbol/Name
LTP
% Chg
SYTA
Siyata Mobile Inc. ...
$ 6.36
-22.34
NRXS
Neuraxis Inc. Commo...
$ 3.57
-15.80
CRI
Carter's Inc. Commo...
$ 33.99
-7.46
NWTN
NWTN Inc. Class B O...
$ 2.20
-7.17
UNH
UnitedHealth Group ...
$ 298.57
-7.15